search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
135 new news items in the last 24 hours
  1. Home
  2. International

Japanese authorities have authorized stem cell-based therapies for Parkinson's disease and heart failure, marking a breakthrough in regenerative medicine.

Ana Maria Eftene
whatsapp
facebook
linkedin
x
copy-link copy-link
7 March 2026, 12:33
main event image
International
Foto: Shutterstock.com
google-preference

Always see our news on Google

Japan has authorized the use of two innovative therapies based on stem cells, representing a major step in regenerative medicine.

These treatments, which target Parkinson's disease and severe heart failure, could become available to patients in a few months. Sumitomo Pharma has obtained conditional approval for the Amchepry therapy, which involves transplanting stem cells into the brains of patients with Parkinson's. A study conducted by Kyoto University demonstrated the safety and efficacy of the treatment, with improvements observed in four out of seven patients monitored for two years.

Additionally, the ReHeart therapy, developed by the startup Cuorips, uses cardiac tissue grafts to improve heart function. These therapies are the first commercial medical products in the world based on iPS cells, developed by Nobel Prize laureate Shinya Yamanaka. The Japanese Minister of Health emphasized the importance of these innovations for patients, not only in Japan but also globally.

Sources

sursa imagine
News.ro
Japonia autorizează în premieră mondială terapii cu celule stem pentru boala Parkinson şi insuficienţă cardiacă severă
sursa imagine
Newsweek
Japonia aprobă primele terapii regenerative cu celule stem pentru Parkinson și insuficiență cardiacă severă * Newsweek România
sursa imagine
Stirile ProTV
Premieră mondială. Japonia autorizează terapii cu celule stem pentru boala Parkinson şi insuficienţa cardiacă severă - Știrile ProTV
sursa imagine
Agerpres
Parkinson/ Japonia aprobă un tratament cu celule stem, o premieră
sursa imagine
G4Media
Japonia aprobă un tratament cu celule stem pentru Parkinson
sursa imagine
Stiripesurse
Japonia aprobă primul tratament cu celule stem pentru boala Parkinson

Latest News

11:56

EXCLUSIVE Romania, Trump and the new Atlantic equation: how much is the bet on a single man worth

11:55

ANSVSA imposed fines of over 550,000 lei following inspections carried out on the Coast for food irregularities.

11:47

The heat waves and drought severely affect agriculture in Europe / Romania is among the few countries with more favorable prospects.

11:45

Two deaths in Michigan linked to the outbreak of cyclosporiasis

11:37

Dozens of Romanian tourists and a lifeguard saved a 15-year-old teenager, caught by currents, on a beach in Greece

See more news

NEWS ON THE SAME TOPICS

event image
Health
Researchers are testing stem cells from umbilical cord for the prevention of brain injuries in premature babies.
event image
EU
Japanese researchers can conduct funded projects through the European program Horizon Europe
event image
International
The Bank of Japan has raised the interest rate to 1%, the highest level since 1995, amid rising global energy prices.
event image
IT&C knowledge
Japan has developed cardboard war drones, easy to transport and assembled in five minutes.
event image
International
The Japanese government has approved a budget supplement of 19 billion dollars to support households affected by the rising cost of living due to the war in Iran.
event image
International
Japan increases visa fees for tourists by 400%
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
Japan therapies stem cells Parkinson's disease

Editor’s Recommendations

main event image
Current Affairs
2 hours ago

Radu Miruță, after the controlled explosion at Cernavodă: "Good news: at the nuclear power plant in Cernavodă, the water level has risen by 2cm compared to yesterday"

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+3
main event image
Current Affairs
24 minutes ago

The Bucharest Court of Appeal suspended the Bolojan Government's regulations regarding the suspension of licenses for drivers with unpaid fines, at the request of the PSD.

Sources
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
2 hours ago
Original Content

EXCLUSIVE | August 4, 2026. Trends in online searches / last 24 hours

main event image
Exclusive
1 hour ago
Original Content

August 4, 2026. TV: What was discussed last night on the news channels

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol